|
Volumn 152, Issue 2, 2001, Pages 89-95
|
Management of severe skin disorders in sarcoidosis;Prise en charge des atteintes cutanées sévères de la sarcoïdose
a |
Author keywords
Sarcoidosis; Skin; Skin disorders; Treatment
|
Indexed keywords
ANTIBIOTIC AGENT;
CORTICOSTEROID;
IMMUNOMODULATING AGENT;
METHOTREXATE;
THALIDOMIDE;
CORTICOSTEROID THERAPY;
CYTOKINE PRODUCTION;
DISEASE SEVERITY;
DRUG INDICATION;
DRUG RESEARCH;
HUMAN;
MACROPHAGE;
MONOCYTE;
REVIEW;
SARCOIDOSIS;
SKIN DISEASE;
SKIN MANIFESTATION;
SYMPTOMATOLOGY;
T LYMPHOCYTE;
ANTI-BACTERIAL AGENTS;
ANTI-INFLAMMATORY AGENTS;
CYTOKINES;
DISEASE PROGRESSION;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
IMMUNOTHERAPY;
MACROPHAGES;
MONOCYTES;
PREDICTIVE VALUE OF TESTS;
SARCOIDOSIS;
SEVERITY OF ILLNESS INDEX;
SKIN DISEASES;
STEROIDS;
T-LYMPHOCYTES;
TREATMENT OUTCOME;
|
EID: 0035022487
PISSN: 0003410X
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (6)
|
References (47)
|